MedTech News

Online tool identifies and ranks community factors that predict cancer disparities
A new study published in JAMA Network Open by the Harvey L. Neiman Health Policy Institute reveals poverty, environmental risks, housing issues, and physical inactivity are top-ranking community-level predictors of disparities in cancer screening, prevalence, and deaths across U.S. counties.

Computational model helps personalize neurostimulation therapy for atrial fibrillation
Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It’s the most common type of arrhythmia and the leading cardiac cause of stroke.

Chemists design candidate drug against diabetes
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

Capturing cancer cells from blood could help doctors choose the right breast cancer treatment
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients’ blood, research from the University of Michigan and the University of Kansas suggests.

Bioinformatics uncovers regenerative therapy for spinal cord injury
Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with no effective treatments. Now, researchers at University of California San Diego School of Medicine have harnessed bioinformatics to fast-track the discovery of a promising new drug for SCI.

A newly-discovered mechanism could contribute to the therapeutic effects of deep brain stimulation
Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to specific regions of the brain, via surgically implanted electrodes.

Injectable antenna could safely power deep-tissue medical implants
The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.

A new clue to ALS and FTD: Faulty protein disrupts brain’s ‘brake’ system
Findings point to promising drug that restores neuron balance and may slow disease progression